-
Comparison between Nugent's and Hay/Ison scoring criteria for the diagnosis of Bacterial Vaginosis in WASP prepared vaginal samples
FrancescoPaolo Antonucci, Walter Mirandola, Carla Fontana
Research Paper: Clinical Investigation
-
Comparison between Nugent's and Hay/Ison scoring criteria for the diagnosis of Bacterial Vaginosis in WASP prepared vaginal samples
FrancescoPaolo Antonucci, Walter Mirandola, Carla Fontana
Research Paper: Clinical Investigation
-
Comparison between Nugent's and Hay/Ison scoring criteria for the diagnosis of Bacterial Vaginosis in WASP prepared vaginal samples
FrancescoPaolo Antonucci, Walter Mirandola, Carla Fontana
Research Paper: Clinical Investigation
-
Comparison between Nugent's and Hay/Ison scoring criteria for the diagnosis of Bacterial Vaginosis in WASP prepared vaginal samples
FrancescoPaolo Antonucci, Walter Mirandola, Carla Fontana
Research Paper: Clinical Investigation
-
Comparison between Nugent's and Hay/Ison scoring criteria for the diagnosis of Bacterial Vaginosis in WASP prepared vaginal samples
FrancescoPaolo Antonucci, Walter Mirandola, Carla Fontana
Research Paper: Clinical Investigation
-
Comparison between Nugent's and Hay/Ison scoring criteria for the diagnosis of Bacterial Vaginosis in WASP prepared vaginal samples
FrancescoPaolo Antonucci, Walter Mirandola, Carla Fontana
Research Paper: Clinical Investigation
-
Comparison between Nugent's and Hay/Ison scoring criteria for the diagnosis of Bacterial Vaginosis in WASP prepared vaginal samples
FrancescoPaolo Antonucci, Walter Mirandola, Carla Fontana
Research Paper: Clinical Investigation
-
Comparison between Nugent's and Hay/Ison scoring criteria for the diagnosis of Bacterial Vaginosis in WASP prepared vaginal samples
FrancescoPaolo Antonucci, Walter Mirandola, Carla Fontana
Research Paper: Clinical Investigation
-
PEARL translational network: an infrastructure for person-centricity and improved clinical outcomes
Frederick A Curro, Dennis A Robbins, Frederick Naftolin, Ashley Grill, Don Vena, Louis Terracio & Van P Thompson
Research Update: Clinical Investigation
-
PEARL translational network: an infrastructure for person-centricity and improved clinical outcomes
Frederick A Curro, Dennis A Robbins, Frederick Naftolin, Ashley Grill, Don Vena, Louis Terracio & Van P Thompson
Research Update: Clinical Investigation
-
PEARL translational network: an infrastructure for person-centricity and improved clinical outcomes
Frederick A Curro, Dennis A Robbins, Frederick Naftolin, Ashley Grill, Don Vena, Louis Terracio & Van P Thompson
Research Update: Clinical Investigation
-
PEARL translational network: an infrastructure for person-centricity and improved clinical outcomes
Frederick A Curro, Dennis A Robbins, Frederick Naftolin, Ashley Grill, Don Vena, Louis Terracio & Van P Thompson
Research Update: Clinical Investigation
-
PEARL translational network: an infrastructure for person-centricity and improved clinical outcomes
Frederick A Curro, Dennis A Robbins, Frederick Naftolin, Ashley Grill, Don Vena, Louis Terracio & Van P Thompson
Research Update: Clinical Investigation
-
PEARL translational network: an infrastructure for person-centricity and improved clinical outcomes
Frederick A Curro, Dennis A Robbins, Frederick Naftolin, Ashley Grill, Don Vena, Louis Terracio & Van P Thompson
Research Update: Clinical Investigation
-
PEARL translational network: an infrastructure for person-centricity and improved clinical outcomes
Frederick A Curro, Dennis A Robbins, Frederick Naftolin, Ashley Grill, Don Vena, Louis Terracio & Van P Thompson
Research Update: Clinical Investigation
-
PEARL translational network: an infrastructure for person-centricity and improved clinical outcomes
Frederick A Curro, Dennis A Robbins, Frederick Naftolin, Ashley Grill, Don Vena, Louis Terracio & Van P Thompson
Research Update: Clinical Investigation
-
Alzheimers disease clinical trials: past failures and future opportunities
Roy Yaari & Ann Hake
Clinical Trail Perspective: Clinical Investigation
-
Alzheimers disease clinical trials: past failures and future opportunities
Roy Yaari & Ann Hake
Clinical Trail Perspective: Clinical Investigation
-
Alzheimers disease clinical trials: past failures and future opportunities
Roy Yaari & Ann Hake
Clinical Trail Perspective: Clinical Investigation
-
Alzheimers disease clinical trials: past failures and future opportunities
Roy Yaari & Ann Hake
Clinical Trail Perspective: Clinical Investigation
-
Alzheimers disease clinical trials: past failures and future opportunities
Roy Yaari & Ann Hake
Clinical Trail Perspective: Clinical Investigation
-
Alzheimers disease clinical trials: past failures and future opportunities
Roy Yaari & Ann Hake
Clinical Trail Perspective: Clinical Investigation
-
Alzheimers disease clinical trials: past failures and future opportunities
Roy Yaari & Ann Hake
Clinical Trail Perspective: Clinical Investigation
-
Alzheimers disease clinical trials: past failures and future opportunities
Roy Yaari & Ann Hake
Clinical Trail Perspective: Clinical Investigation
-
News: Effectiveness of Tamiflu during swine flu pandemic assessed
News and Views: Clinical Investigation
-
News: Effectiveness of Tamiflu during swine flu pandemic assessed
News and Views: Clinical Investigation
-
News: Effectiveness of Tamiflu during swine flu pandemic assessed
News and Views: Clinical Investigation
-
News: Effectiveness of Tamiflu during swine flu pandemic assessed
News and Views: Clinical Investigation
-
News: Effectiveness of Tamiflu during swine flu pandemic assessed
News and Views: Clinical Investigation
-
News: Effectiveness of Tamiflu during swine flu pandemic assessed
News and Views: Clinical Investigation
-
News: Effectiveness of Tamiflu during swine flu pandemic assessed
News and Views: Clinical Investigation
-
News: Effectiveness of Tamiflu during swine flu pandemic assessed
News and Views: Clinical Investigation
-
Clinical trials of idiopathic pulmonary fibrosis: choosing the (right) primary end point
Paolo Spagnolo,Fabrizio Luppi
Review Article: Clinical Investigation
-
Clinical trials of idiopathic pulmonary fibrosis: choosing the (right) primary end point
Paolo Spagnolo,Fabrizio Luppi
Review Article: Clinical Investigation
-
Clinical trials of idiopathic pulmonary fibrosis: choosing the (right) primary end point
Paolo Spagnolo,Fabrizio Luppi
Review Article: Clinical Investigation
-
Clinical trials of idiopathic pulmonary fibrosis: choosing the (right) primary end point
Paolo Spagnolo,Fabrizio Luppi
Review Article: Clinical Investigation
-
Clinical trials of idiopathic pulmonary fibrosis: choosing the (right) primary end point
Paolo Spagnolo,Fabrizio Luppi
Review Article: Clinical Investigation
-
Clinical trials of idiopathic pulmonary fibrosis: choosing the (right) primary end point
Paolo Spagnolo,Fabrizio Luppi
Review Article: Clinical Investigation
-
Clinical trials of idiopathic pulmonary fibrosis: choosing the (right) primary end point
Paolo Spagnolo,Fabrizio Luppi
Review Article: Clinical Investigation
-
Clinical trials of idiopathic pulmonary fibrosis: choosing the (right) primary end point
Paolo Spagnolo,Fabrizio Luppi
Review Article: Clinical Investigation
-
Autoregressive integrated moving average in clinical trials
Ton Cleophas
Commentary: Clinical Investigation
-
Autoregressive integrated moving average in clinical trials
Ton Cleophas
Commentary: Clinical Investigation
-
Autoregressive integrated moving average in clinical trials
Ton Cleophas
Commentary: Clinical Investigation
-
Autoregressive integrated moving average in clinical trials
Ton Cleophas
Commentary: Clinical Investigation
-
Autoregressive integrated moving average in clinical trials
Ton Cleophas
Commentary: Clinical Investigation
-
Autoregressive integrated moving average in clinical trials
Ton Cleophas
Commentary: Clinical Investigation
-
Autoregressive integrated moving average in clinical trials
Ton Cleophas
Commentary: Clinical Investigation
-
Autoregressive integrated moving average in clinical trials
Ton Cleophas
Commentary: Clinical Investigation
-
Pharmacological treatment of gastrointestinal stromal tumors: update from recent clinical trials
M Agulnik, K Adekola, J Wayne
Review: Clinical Trail Outcomes: Clinical Investigation
-
Pharmacological treatment of gastrointestinal stromal tumors: update from recent clinical trials
M Agulnik, K Adekola, J Wayne
Review: Clinical Trail Outcomes: Clinical Investigation
-
Pharmacological treatment of gastrointestinal stromal tumors: update from recent clinical trials
M Agulnik, K Adekola, J Wayne
Review: Clinical Trail Outcomes: Clinical Investigation
-
Pharmacological treatment of gastrointestinal stromal tumors: update from recent clinical trials
M Agulnik, K Adekola, J Wayne
Review: Clinical Trail Outcomes: Clinical Investigation
-
Pharmacological treatment of gastrointestinal stromal tumors: update from recent clinical trials
M Agulnik, K Adekola, J Wayne
Review: Clinical Trail Outcomes: Clinical Investigation
-
Pharmacological treatment of gastrointestinal stromal tumors: update from recent clinical trials
M Agulnik, K Adekola, J Wayne
Review: Clinical Trail Outcomes: Clinical Investigation
-
Pharmacological treatment of gastrointestinal stromal tumors: update from recent clinical trials
M Agulnik, K Adekola, J Wayne
Review: Clinical Trail Outcomes: Clinical Investigation
-
Pharmacological treatment of gastrointestinal stromal tumors: update from recent clinical trials
M Agulnik, K Adekola, J Wayne
Review: Clinical Trail Outcomes: Clinical Investigation
-
Opportunities for innovation in the design and execution of clinical trials
John J Orloff, Jeffrey Kralstein
Editorial: Clinical Investigation
-
Opportunities for innovation in the design and execution of clinical trials
John J Orloff, Jeffrey Kralstein
Editorial: Clinical Investigation
-
Opportunities for innovation in the design and execution of clinical trials
John J Orloff, Jeffrey Kralstein
Editorial: Clinical Investigation
-
Opportunities for innovation in the design and execution of clinical trials
John J Orloff, Jeffrey Kralstein
Editorial: Clinical Investigation
-
Opportunities for innovation in the design and execution of clinical trials
John J Orloff, Jeffrey Kralstein
Editorial: Clinical Investigation
-
Opportunities for innovation in the design and execution of clinical trials
John J Orloff, Jeffrey Kralstein
Editorial: Clinical Investigation
-
Opportunities for innovation in the design and execution of clinical trials
John J Orloff, Jeffrey Kralstein
Editorial: Clinical Investigation
-
Opportunities for innovation in the design and execution of clinical trials
John J Orloff, Jeffrey Kralstein
Editorial: Clinical Investigation
-
Challenges of developing new drugs for childhood cancers
Frank M Balis, Elizabeth Fox
Clinical Trail Perspective: Clinical Investigation
-
Challenges of developing new drugs for childhood cancers
Frank M Balis, Elizabeth Fox
Clinical Trail Perspective: Clinical Investigation
-
Challenges of developing new drugs for childhood cancers
Frank M Balis, Elizabeth Fox
Clinical Trail Perspective: Clinical Investigation
-
Challenges of developing new drugs for childhood cancers
Frank M Balis, Elizabeth Fox
Clinical Trail Perspective: Clinical Investigation
-
Challenges of developing new drugs for childhood cancers
Frank M Balis, Elizabeth Fox
Clinical Trail Perspective: Clinical Investigation
-
Challenges of developing new drugs for childhood cancers
Frank M Balis, Elizabeth Fox
Clinical Trail Perspective: Clinical Investigation
-
Challenges of developing new drugs for childhood cancers
Frank M Balis, Elizabeth Fox
Clinical Trail Perspective: Clinical Investigation
-
Challenges of developing new drugs for childhood cancers
Frank M Balis, Elizabeth Fox
Clinical Trail Perspective: Clinical Investigation
-
New developments in the treatment of diabetic macular edema: latest clinical evidence
Shani Golan, Anat Lowenstein
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the treatment of diabetic macular edema: latest clinical evidence
Shani Golan, Anat Lowenstein
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the treatment of diabetic macular edema: latest clinical evidence
Shani Golan, Anat Lowenstein
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the treatment of diabetic macular edema: latest clinical evidence
Shani Golan, Anat Lowenstein
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the treatment of diabetic macular edema: latest clinical evidence
Shani Golan, Anat Lowenstein
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the treatment of diabetic macular edema: latest clinical evidence
Shani Golan, Anat Lowenstein
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the treatment of diabetic macular edema: latest clinical evidence
Shani Golan, Anat Lowenstein
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the treatment of diabetic macular edema: latest clinical evidence
Shani Golan, Anat Lowenstein
Review: Clinical Trail Outcomes: Clinical Investigation